Literature DB >> 28940160

Optimal Therapy in Locally Advanced Esophageal Cancer: a National Cancer Database Analysis.

William M Whited1, Jaimin R Trivedi1, Emily R Bond1, Victor H van Berkel1, Matthew P Fox2.   

Abstract

Entities:  

Keywords:  Esophageal cancer; National Cancer Database

Year:  2017        PMID： 28940160     DOI： 10.1007/s11605-017-3548-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  19 in total

1.  Surgical resection for locoregional esophageal cancer is underutilized in the United States.

Authors:  Attila Dubecz; Boris Sepesi; Renato Salvador; Marek Polomsky; Thomas J Watson; Daniel P Raymond; Carolyn E Jones; Virginia R Litle; Juan P Wisnivesky; Jeffrey H Peters
Journal:  J Am Coll Surg       Date:  2010-10-25       Impact factor: 6.113

2.  Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer.

Authors:  Paul J Speicher; Brian R Englum; Asvin M Ganapathi; Xiaofei Wang; Matthew G Hartwig; Thomas A D'Amico; Mark F Berry
Journal:  Ann Surg       Date:  2017-04       Impact factor: 12.969

3.  Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

Authors:  Laurent Bedenne; Pierre Michel; Olivier Bouché; Chantal Milan; Christophe Mariette; Thierry Conroy; Denis Pezet; Bernard Roullet; Jean-François Seitz; Jean-Philippe Herr; Bernard Paillot; Patrick Arveux; Franck Bonnetain; Christine Binquet
Journal:  J Clin Oncol       Date:  2007-04-01       Impact factor: 44.544

4.  Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation.

Authors:  Stephen G Swisher; Jennifer Moughan; Ritsuko U Komaki; Jaffer A Ajani; Tsung T Wu; Wayne L Hofstetter; Andre A Konski; Christopher G Willett
Journal:  J Thorac Oncol       Date:  2016-10-08       Impact factor: 15.609

5.  Underuse of esophagectomy as treatment for resectable esophageal cancer.

Authors:  E Carter Paulson; Jin Ra; Katrina Armstrong; Christopher Wirtalla; Francis Spitz; Rachel Rapaport Kelz
Journal:  Arch Surg       Date:  2008-12

6.  Mortality after esophagectomy is heavily impacted by center volume: retrospective analysis of the Nationwide Inpatient Sample.

Authors:  Hans F Fuchs; Cristina R Harnsberger; Ryan C Broderick; David C Chang; Bryan J Sandler; Garth R Jacobsen; Michael Bouvet; Santiago Horgan
Journal:  Surg Endosc       Date:  2016-09-22       Impact factor: 4.584

7.  Impact of Positive Margins on Survival in Patients Undergoing Esophagogastrectomy for Esophageal Cancer.

Authors:  Jeffrey Javidfar; Paul J Speicher; Matthew G Hartwig; Thomas A D'Amico; Mark F Berry
Journal:  Ann Thorac Surg       Date:  2015-11-11       Impact factor: 4.330

8.  Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer.

Authors:  David P Kelsen; Katryn A Winter; Leonard L Gunderson; Joanne Mortimer; Norman C Estes; Daniel G Haller; Jaffer A Ajani; Walter Kocha; Bruce D Minsky; Jack A Roth; Christopher G Willett
Journal:  J Clin Oncol       Date:  2007-08-20       Impact factor: 44.544

9.  Utilization of surgical treatment for local and locoregional esophageal cancer: Analysis of the National Cancer Data Base.

Authors:  Lauren J Taylor; Caprice C Greenberg; Anne O Lidor; Glen E Leverson; James D Maloney; Ryan A Macke
Journal:  Cancer       Date:  2016-09-28       Impact factor: 6.860

10.  Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

Authors:  Joel Tepper; Mark J Krasna; Donna Niedzwiecki; Donna Hollis; Carolyn E Reed; Richard Goldberg; Krystyna Kiel; Christopher Willett; David Sugarbaker; Robert Mayer
Journal:  J Clin Oncol       Date:  2008-03-01       Impact factor: 44.544
View more
  2 in total

1.  Influence of Neoadjuvant Radiation Dose on Patients Undergoing Esophagectomy and Survival in Locally Advanced Esophageal Cancer.

Authors:  Mickey S Ising; Katy Marino; Jaimin R Trivedi; Adam A Rojan; Neal E Dunlap; Victor van Berkel; Matthew P Fox
Journal:  J Gastrointest Surg       Date:  2019-02-20       Impact factor: 3.452

2.  Postoperative lymphatic recurrence distribution and delineation of the radiation field in lower thoracic squamous cell esophageal carcinomas: a real-world study.

Authors:  Rongxu Du; Songqing Fan; Shuchai Zhu; Jie Li; Anhui Shi; Xiaobin Wang; Xia Hou; Cheng Zeng; Dan Guo; Rongrong Tian; Dan Yang; Leilei Jiang; Xin Dong; Rong Yu; Huiming Yu; Dongming Li
Journal:  Radiat Oncol       Date:  2022-03-05       Impact factor: 3.481
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.